You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is 3.5 kg term male baby, born of uncomplicated pregnancy, developed, respiratory distress at birth, not responded to surfactant, ECHO finding revealed nothing abnormal, X–ray showed ground glass appearance and culture negative. Apgars 4 and 5 at 1 and 5 minutes. History of one month female sibling died before. What is the diagnosis ? and explain in detail?
"Respiratory distress in an infant along with a positive family history of similarly affected newborn infants strongly suggests, pulmonary alveolar proteinosis".
Pulmonary alveolar proteinosis 

Pulmonary alveolar proteinosis is a disorder characterized by the intraalveolar accumulation of pulmonary surfactant.
Two clinically distinct forms of pulmonary alveolar proteinosis are seen -


Fatal form                                -->          Presenting shortly after birth (congenital PAP)

u Gradually progressive form -->           Presenting in older infants and children
Pathology

Although the mechanisms that lead to alveolar proteinosis are undefined, histological findings suggests that they result in a disruption of pulmonary surfactant metabolism.
The main surface tension lowering agent in surfactant is phospholipids le. primary dipalmitol phosphatidyl choline.
However DPCC needs surfactant protein (in endogenous and natural surfactants) for efficient dispersion which enables the formation of a phospholipid monolayer on the alveolar surface.
There are two surfactant proteins present in the body i.e., protein A and protein B.
In pulmonary alveolar proteinosis, there is absence of protein B.
In the absence of protein B, the rapid spread and absorption of the phospholipid (DPCC) does not take place so they cannot form a phospholipid monolayer on the alveolar surface.
This in turn leads to failure of expansion of alveoli leading to poor cardiorespiratory adaptation at birth.

Clinical manifestation -

This disorder is immediately apparent in the newborn period and rapidly leads to respiratory failure.
Congenital pulmonary alveolar proteinosis is clinically and radiographically indistinguishable from more common disorders of the newborn that lead to respiratory failure including pneumonia, generalized bacterial infection, respiratory distress syndrome and total anomalous pulmonary venous return with obstruction.

Diagnosis

Histopathological examination of lung biopsy specimen is the gold standard for diagnosis.
On histopathological examination distal air spaces are filled with a granular, eosinophillic material that stains

positively with periodic - acid schiff reagent and is diastase resistant.
Treatment

Untreated, alveolar proteinosis in newborns is rapidly fatal and no successful medical therapy has been developed.
Repeated bronchoalveolar lavage is a temporizing measure.
Lung transplantation is the only therapeutic option but its use is limited by concerns about disease recurrence.